Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, 100044, China.
Department of Pathology, Peking University People's Hospital, Beijing, 100044, China.
Arthritis Res Ther. 2021 Feb 10;23(1):54. doi: 10.1186/s13075-021-02432-y.
The growing utilization of needle biopsy has challenged the current pathology consensus of IgG4-related disease (IgG4-RD). The aims of this study were to identify the histological characteristics of needle biopsy and surgical specimens and evaluate the ability of needle biopsy in histological diagnosis of IgG4-RD.
Biopsies from patients who were referred to as IgG4-RD by the 2019 ACR/EULAR IgG4-RD classification criteria in Peking University People's Hospital from 2012 to 2019 were re-evaluated. Typical histological features and diagnostic categories were compared between needle biopsy and surgical biopsy.
In total, 69 patients met the 2019 ACR/EULAR classification criteria and 72 biopsies of them were re-evaluated. All cases showed lymphoplasmacytic infiltrate, while storiform fibrosis and obliterative phlebitis were only present in 35 (48.6%) and 23 (31.9%) specimens, respectively. Storiform fibrosis was more likely to be seen in retroperitoneum lesion (P = 0.033). Surgical biopsy showed significantly higher IgG4+ plasma cells/high-power field (IgG4/HPF) count (P < 0.01) and higher proportion of IgG4/HPF > 10 (P < 0.01). No significant difference was observed with regard to the ratio of IgG4+ plasma cells/IgG+ plasma cells (IgG4/IgG) (P = 0.399), storiform fibrosis (P = 0.739), and obliterative phletibis (P = 0.153). According to the 2011 comprehensive diagnostic criteria, patients who performed a needle biopsy were less likely to be probable IgG4-RD (P = 0.045). Based on the 2011 pathology consensus, needle biopsy was less likely to be diagnosed as IgG4-RD (P < 0.01), especially to be highly suggestive IgG4-RD (P < 0.01). Only 1/18 (5.6%) needle salivary specimens fulfilled the cutoff of IgG4/HPF > 100, which was significantly less than 15/23 (65.2%) of surgical ones (P < 0.01).
Needle biopsy shows an inferiority in detecting IgG4/HPF count but not in IgG4/IgG ratio, storiform fibrosis, and obliterative phlebitis. Compared with surgical samples, needle biopsy is less likely to obtain a histological diagnosis of IgG4-RD. A different IgG4/HPF threshold for needle biopsy of the salivary glands may be considered.
随着针吸活检的广泛应用,对目前 IgG4 相关疾病(IgG4-RD)的病理共识提出了挑战。本研究旨在明确针吸活检和手术标本的组织学特征,并评估针吸活检在 IgG4-RD 组织学诊断中的作用。
对 2012 年至 2019 年期间在北京大学人民医院被 2019 年 ACR/EULAR IgG4-RD 分类标准定义为 IgG4-RD 的患者的活检进行重新评估。比较了针吸活检和手术活检的典型组织学特征和诊断类别。
共有 69 例患者符合 2019 年 ACR/EULAR 分类标准,对其中 72 例活检进行了重新评估。所有病例均表现为淋巴浆细胞浸润,而 35 例(48.6%)和 23 例(31.9%)标本仅显示纤维分隔样和闭塞性静脉炎。纤维分隔样更可能见于腹膜后病变(P=0.033)。手术活检的 IgG4+浆细胞/高倍视野(IgG4/HPF)计数显著更高(P<0.01),IgG4/HPF>10 的比例更高(P<0.01)。IgG4+浆细胞/IgG+浆细胞(IgG4/IgG)比值(P=0.399)、纤维分隔样(P=0.739)和闭塞性静脉炎(P=0.153)的比例无显著差异。根据 2011 年综合诊断标准,行针吸活检的患者更不可能被诊断为可能的 IgG4-RD(P=0.045)。根据 2011 年的病理共识,针吸活检更不可能被诊断为 IgG4-RD(P<0.01),尤其是高度提示性 IgG4-RD(P<0.01)。仅有 1/18(5.6%)针吸唾液标本的 IgG4/HPF>100,明显低于 23/23(65.2%)手术标本(P<0.01)。
针吸活检在检测 IgG4/HPF 计数方面存在不足,但在 IgG4/IgG 比值、纤维分隔样和闭塞性静脉炎方面并无差异。与手术标本相比,针吸活检更不可能获得 IgG4-RD 的组织学诊断。对于唾液腺的针吸活检,可能需要考虑不同的 IgG4/HPF 阈值。